Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1CNS 1

Conditions

Oligodendroglioma 1Lymphoma, Follicular 1Glioma 1Glioblastoma 1Astrocytoma 1

Interventions

Filgrastim 4Temozolomide 2Psychiatric Rehabilitation 2Cyproheptadine 2Carmustine 2Bortezomib 2varlilumab 1trametinib 1sonidegib 1sargramostim 1ribociclib 1poly ICLC 1ixabepilone 1imetelstat 1exatecan 1etoposide phosphate 1entinostat 1carboxyamido-triazole 1becatecarin 1Vorinostat 1Transurethral Resection of Bladder 1Topotecan 1Thiotepa 1Thalidomide 1Spinal Puncture 1Specimen Handling 1Radiotherapy 1Postoperative Period 1Peripheral Blood Stem Cell Transplantation 1Pemetrexed 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Oligodendroglioma × Eflornithine × Lymphoid × Clear all
NCT07468136 2026-04-13

Retifanlimab With or Without Difluoromethylornithine for the Treatment of Progressive High Grade Gliomas

Mayo Clinic

Phase 1/2 Not yet recruiting
33 enrolled
CNSLymphoid

Astrocytoma, Glioblastoma, Glioma, Lymphoma, Follicular, Oligodendroglioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡